CorMedix Inc.
CorMedix Inc. scores highest on Price (80) and lowest on Earnings (47). Its PosiPenta is 58.56 out of 100, around the middle of similar companies.
On the Penta Grid this week, CorMedix Inc. is Grid #163 of 837 in the Healthcare sector in United States, and Grid #787 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| CorMedix Inc. | 58.56 | 80 | 47 | 50 | 67 | 49 |
| Pacific Biosciences of California, Inc. | 28.28 | 0 | 44 | 52 | 2 | 44 |
| Candel Therapeutics, Inc. | 40.79 | 14 | 50 | 62 | 34 | 44 |
| Gyre Therapeutics, Inc. | 52.87 | 12 | 77 | 57 | 68 | 51 |
| OrthoPediatrics Corp. | 55.20 | 32 | 49 | 81 | 53 | 62 |
| Arbutus Biopharma Corporation | 66.02 | 67 | 44 | 72 | 85 | 63 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 3.54 |
| P/B ratio | 1.23 |
EEarnings
| Trailing EPS | ₹194.17 |
| Forward EPS | ₹33.15 |
NNitro
| Price | 687.63 |
| 52-week high | 1233.19 |
| 52-week low | 580.60 |
| Fall from 52-week high | 44.2% |
TTorque
| Return on equity (ROE) | 54.93% |
| Debt-to-equity | 0.32 |
AAnchor
| Beta (price swings) | 1.41 |
| Market cap | ₹5,359 Cr |
| Insider holding | 7.61% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is CorMedix Inc.'s PosiPenta score?
CorMedix Inc.'s PosiPenta is 58.56 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does CorMedix Inc. stand on the Penta Grid?
On the Penta Grid this week, CorMedix Inc. is Grid #163 of 837 in the Healthcare sector in United States, and Grid #787 of 4,000 in United States.
Which PosiPenta pillar is strongest for CorMedix Inc.?
Price (valuation), with a score of 80 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for CorMedix Inc.?
Earnings (growth), with a score of 47 out of 100: around the middle of similar companies.
Has CorMedix Inc.'s PosiPenta changed since last week?
Yes, it rose 1.36 points, from 57.20 to 58.56.
PositoAI is for research and education only and is not investment advice.